Will CALR be the new JAK2 ?

Professor Constantinescu and Professor Kiladjian discuss the impact of the presence of the CALR mutation on patients with myeloproliferative neoplasms.

 

Professor Stefan Constantinescu:

Biography/Abstract/Reference List     Presentation

Professor Jean-Jacques Kiladjian:

Biography/Abstract/Reference List     Presentation

back to top